Peng Y - Search Results

1

Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection.

Yang Y, Yang M, Peng Y, Liang Y, Wei J, Xing L, Guo L, Li X, Li J, Wang J, Li M, Xu Z, Zhang M, Wang F, Shi Y, Yuan J, Liu Y. Yang Y, et al. Among authors: peng y. Nat Microbiol. 2022 Mar;7(3):423-433. doi: 10.1038/s41564-021-01051-2. Epub 2022 Feb 7. Nat Microbiol. 2022. PMID: 35132197

2

Delayed peak of human infections and ongoing reassortment of H7N9 avian influenza virus in the newly affected western Chinese provinces during Wave Five.

Li J, Chen C, Wei J, Huang H, Peng Y, Bi Y, Liu Y, Yang Y. Li J, et al. Among authors: peng y. Int J Infect Dis. 2019 Nov;88:80-87. doi: 10.1016/j.ijid.2019.09.002. Epub 2019 Sep 6. Int J Infect Dis. 2019. PMID: 31499209 Free article.

3

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys.

Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, Shan C, Jiang W, Li Z, Gu C, Chen B, Hu X, Yao Y, Min J, Zhang H, Chen Y, Gao G, Tang P, Li G, Wang A, Wang L, Zhang J, Chen S, Gui X, Yuan Z, Liu D. Wang S, et al. Among authors: peng y. Nat Commun. 2020 Nov 13;11(1):5752. doi: 10.1038/s41467-020-19568-1. Nat Commun. 2020. PMID: 33188207 Free PMC article.

4

Dominant subtype switch in avian influenza viruses during 2016-2019 in China.

Bi Y, Li J, Li S, Fu G, Jin T, Zhang C, Yang Y, Ma Z, Tian W, Li J, Xiao S, Li L, Yin R, Zhang Y, Wang L, Qin Y, Yao Z, Meng F, Hu D, Li D, Wong G, Liu F, Lv N, Wang L, Fu L, Yang Y, Peng Y, Ma J, Sharshov K, Shestopalov A, Gulyaeva M, Gao GF, Chen J, Shi Y, Liu WJ, Chu D, Huang Y, Liu Y, Liu L, Liu W, Chen Q, Shi W. Bi Y, et al. Among authors: peng y. Nat Commun. 2020 Nov 20;11(1):5909. doi: 10.1038/s41467-020-19671-3. Nat Commun. 2020. PMID: 33219213 Free PMC article.

5

A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes.

Guo Y, Huang L, Zhang G, Yao Y, Zhou H, Shen S, Shen B, Li B, Li X, Zhang Q, Chen M, Chen D, Wu J, Fu D, Zeng X, Feng M, Pi C, Wang Y, Zhou X, Lu M, Li Y, Fang Y, Lu YY, Hu X, Wang S, Zhang W, Gao G, Adrian F, Wang Q, Yu F, Peng Y, Gabibov AG, Min J, Wang Y, Huang H, Stepanov A, Zhang W, Cai Y, Liu J, Yuan Z, Zhang C, Lou Z, Deng F, Zhang H, Shan C, Schweizer L, Sun K, Rao Z. Guo Y, et al. Among authors: peng y. Nat Commun. 2021 May 11;12(1):2623. doi: 10.1038/s41467-021-22926-2. Nat Commun. 2021. PMID: 33976198 Free PMC article.

6

Simultaneous detection of Zika, chikungunya, dengue, yellow fever, West Nile, and Japanese encephalitis viruses by a two-tube multiplex real-time RT-PCR assay.

Xu Z, Peng Y, Yang M, Li X, Wang J, Zou R, Liang J, Fang S, Liu Y, Yang Y. Xu Z, et al. Among authors: peng y. J Med Virol. 2022 Jun;94(6):2528-2536. doi: 10.1002/jmv.27658. Epub 2022 Feb 22. J Med Virol. 2022. PMID: 35146775

7

Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.

Yang M, Li J, Deng S, Fan H, Peng Y, Ye G, Wang J, Wei J, Jiang X, Xu Z, Qing L, Wang F, Yang Y, Liu Y. Yang M, et al. Among authors: peng y. Cells. 2022 Jan 30;11(3):487. doi: 10.3390/cells11030487. Cells. 2022. PMID: 35159296 Free PMC article.

8

Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice.

Lu M, Liu K, Peng Y, Ding Z, Li Y, Tendu A, Hu X, Gao G, Guo W, Liu H, Rao J, Zhao J, Chen M, Yuan Z, Wong G, Shan C, Yao Y, Lan J. Lu M, et al. Among authors: peng y. Virol Sin. 2022 Aug;37(4):581-590. doi: 10.1016/j.virs.2022.05.006. Epub 2022 Jun 1. Virol Sin. 2022. PMID: 35659605 Free PMC article.

9

An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity.

Zhang H, Gong X, Peng Y, Saravanan KM, Bian H, Zhang JZH, Wei Y, Pan Y, Yang Y. Zhang H, et al. Among authors: peng y. Front Chem. 2022 Jul 12;10:933102. doi: 10.3389/fchem.2022.933102. eCollection 2022. Front Chem. 2022. PMID: 35903186 Free PMC article.

10

Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro.

Lu L, Peng Y, Yao H, Wang Y, Li J, Yang Y, Lin Z. Lu L, et al. Among authors: peng y. Antiviral Res. 2022 Oct;206:105389. doi: 10.1016/j.antiviral.2022.105389. Epub 2022 Aug 17. Antiviral Res. 2022. PMID: 35985407 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,127 results

Search Page

Filters